Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal KaryotypeBrunangelo Falini|New England Journal of Medicine|2005Cited by 1.9k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory CommitteeElı́as Campo, Ari Melnick, Andrew D. Zelenetz et al.|Blood|2022Cited by 1.5k
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotypeSusanne Schnittger, Brunangelo Falini|Blood|2005Cited by 703
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical featuresBrunangelo Falini, Cristina Mecucci, Ildo Nicoletti|Blood|2006Cited by 562
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Chiara Cattaneo et al.|The Lancet Haematology|2020Cited by 553